Impact of vasopressin and serum osmolarity on outcome in acute heart failure

Back

HFA Premium Access

Impact of vasopressin and serum osmolarity on outcome in acute heart failure

Session: Heart Failure ePosters - focus on Chronic Heart Failure 3

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Guzik (Wroclaw, PL)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Mateusz Guzik

Institute of Heart Diseases, Wroclaw Medical University, Wroclaw (Poland)

0 follower

35 more presentations in this session

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the REWIND randomized trial

Speaker: Professor K. Branch (Seattle, US)

Access

Abstract

Slides

Prognostic value of pulse pressure in heart failure with preserved ejection fraction: findings from the RICA registry

Speaker: Doctor I. Bravo Candela (Sevilla, ES)

Access

Abstract

Slides

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

Speaker: Doctor J. De Juan Baguda (Madrid, ES)

Access

Abstract

Slides

Sacubitril/valsartan use patterns among older adults with heart failure in routine care: a US population-based cohort study of >25,000 medicare beneficiaries

Speaker: Doctor A. Bhatt (Boston, US)

Access

Abstract

Slides

Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis

Speaker: Doctor R. Cordovez (Cebu City, PH)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 3

Speakers: Doctor M. Guzik, Professor K. Branch, Doctor I. Bravo Candela, Doctor J. De Juan Baguda, Doctor A. Bhatt...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources